Phase 2 Malignant Pleural Mesothelioma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Malignant Pleural Mesotheliomas
Beijing Biotech36 enrolled1 locationNCT07510815
Recruiting
Phase 2
The IMmunotherapy Pleural 5-ALA PDT
Malignant Pleural MesotheliomaMesotheliomas Pleural
University Hospital, Lille20 enrolled1 locationNCT04400539
Recruiting
Phase 2
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma
Hyogo Medical University25 enrolled1 locationNCT06318286
Recruiting
Phase 1Phase 2
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma
University Hospital, Antwerp15 enrolled3 locationsNCT05765084
Completed
Phase 2
B2P2M2: Phase II trial of BNC105P as 2nd line chemotherapy for advanced malignant pleural mesothelioma
Advanced malignant pleural mesothelioma
University of Sydney60 enrolled1 locationACTRN12610000093088